Role of gut microbiota in identification of novel TCM-derived active metabolites

Abstract

Traditional Chinese Medicine (TCM) has been extensively used to ameliorate diseases in Asia for over thousands of years. However, owing to a lack of formal scientific validation, the absence of information regarding the mechanisms underlying TCMs restricts their application. After oral administration, TCM herbal ingredients frequently are not directly absorbed by the host, but rather enter the intestine to be transformed by gut microbiota. The gut microbiota is a microbial community living in animal intestines, and functions to maintain host homeostasis and health. Increasing evidences indicate that TCM herbs closely affect gut microbiota composition, which is associated with the conversion of herbal components into active metabolites. These may significantly affect the therapeutic activity of TCMs. Microbiota analyses, in conjunction with modern multiomics platforms, can together identify novel functional metabolites and form the basis of future TCM research.

Keywords

Traditional Chinese Medicine / herbs / microbiota / transformation / multiomics

References

[1] Alexandrov P, Zhai Y, Li W, Lukiw W (2019) Lipopolysaccharidestimulated, NF-kB-, miRNA-146aand miRNA-155-mediated molecular-genetic communication between the human gastroin testinal tract microbiome and the brain. Folia Neuropathol 57:211–219

[2] Amaretti A, Gozzoli C, Simone M, Raimondi S, Righini L, PerezBrocal V, Garcia-Lopez R, Moya A, Rossi M (2019) Profiling of protein degraders in cultures of human gut microbiota. Front Microbiol 10:2614

[3] Anlu W, Dongcheng C, He Z, Qiuyi L, Yan Z, Yu Q, Hao X, Keji C (2019) Using herbal medicine to target the “microbiota-metabolism-immunity” axis as possible therapy for cardiovascular disease. Pharmacol Res 142:205–222

[4] Bailly C (2019) Irinotecan: 25 years of cancer treatment. Pharmacol Res 148:104398

[5] Baumann U, Bisping B (1995) Proteolysis during tempe fermentation. Food Microbiol 12:39–47

[6] Bayer EA, Lamed R, White BA, Flint HJ (2008) From cellulosomes to cellulosomics. Chem Rec 8:364–377

[7] Bei WJ, Guo J, Wu HY, Cao Y (2012) Lipid-regulating effect of traditional chinese medicine: mechanisms of actions. Evid Based Complement Altern Med 2012:970635

[8] Belcher SM, Cline JM, Conley J, Groeters S, Jefferson WN, Law M, Mackey E, Suen AA, Williams CJ, Dixon D (2019) Endocrine disruption and reproductive pathology. Toxicol Pathol 47:1049–1071

[9] Blachier F, Mariotti F, Huneau JF, Tome D (2007) Effects of amino acid-derived luminal metabolites on the colonic epithelium and physiopathological consequences. Amino Acids 33:547–562

[10] Blaut M, Clavel T (2007) Metabolic diversity of the intestinal microbiota: implications for health and disease. J Nutr 137:751S–755S

[11] Bone E, Tamm A, Hill M (1976) The production of urinary phenols by gut bacteria and their possible role in the causation of large bowel cancer. Am J Clin Nutr 29:1448–1454

[12] Bouhnik Y, Raskine L, Simoneau G, Vicaut E, Neut C, Flourie B, Brouns F, Bornet FR (2004) The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study. Am J Clin Nutr 80:1658–1664

[13] Boyapati RK, Rossi AG, Satsangi J, Ho GT (2016) Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications. Mucosal Immunol 9:567–582

[14] Burokas A, Arboleya S, Moloney RD, Peterson VL, Murphy K, Clarke G, Stanton C, Dinan TG, Cryan JF (2017) Targeting the microbiota-gut-brain axis: prebiotics have anxiolytic and antidepressant-like effects and reverse the impact of chronic stress in mice. Biol Psychiatry 82:472–487

[15] Canyelles M, Tondo M, Cedo L, Farras M, Escola-Gil JC, BlancoVaca F (2018) Trimethylamine N-Oxide: a link among diet, gut microbiota, gene regulation of liver and intestine cholesterol homeostasis and HDL function. Int J Mol Sci 19(10):3228

[16] Carqueijeiro I, Langley C, Grzech D, Koudounas K, Papon N, O’Connor SE, Courdavault V (2019) Beyond the semi-synthetic artemisinin: metabolic engineering of plant-derived anti-cancer drugs. Curr Opin Biotechnol 65:17–24

[17] Chang CJ, Lin CS, Lu CC, Martel J, Ko YF, Ojcius DM, Tseng SF, Wu TR, Chen YY, Young JD (2015) Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nat Commun 6:7489

[18] Chang CJ, Lin TL, Tsai YL, Wu TR, Lai WF, Lu CC, Lai HC (2019) Next generation probiotics in disease amelioration. J Food Drug Anal 27:615–622

[19] Chang R (2002) Bioactive polysaccharides from traditional Chinese medicine herbs as anticancer adjuvants. J Altern Complement Med 8:559–565

[20] Chen C, You LJ, Huang Q, Fu X, Zhang B, Liu RH, Li C (2018a) Modulation of gut microbiota by mulberry fruit polysaccharide treatment of obese diabetic db/db mice. Food Funct 9:3732–3742

[21] Chen J, Hu Y, Chen L, Liu W, Mu Y, Liu P (2019) The effect and mechanisms of Fuzheng Huayu formula against chronic liver diseases. Biomed Pharmacother 114:108846

[22] Chen L, Krekels EHJ, Verweij PE, Buil JB, Knibbe CAJ, Bruggemann RJM (2020) Pharmacokinetics and pharmacodynamics of posaconazole. Drugs 80:671–695

[23] Chen M, Liao Z, Lu B, Wang M, Lin L, Zhang S, Li Y, Liu D, Liao Q, Xie Z (2018b) Huang-Lian-Jie-Du-Decoction ameliorates hyperglycemia and insulin resistant in association with gut microbiota modulation. Front Microbiol 9:2380

[24] Chen Q, Xiao S, Li Z, Ai N, Fan X (2015) Chemical and metabolic profiling of Si-Ni decoction analogous formulae by high performance liquid chromatography-mass spectrometry. Sci Rep 5:11638

[25] Chen Y, Yao F, Ming K, Wang D, Hu Y, Liu J (2016) Polysaccharides from traditional chinese medicines: extraction, purification, modification, and biological activity. Molecules 21:1705

[26] Chi X, Wang S, Baloch Z, Zhang H, Li X, Zhang Z, Zhang H, Dong Z, Lu Y, Yu H (2019) Research progress on classical traditional Chinese medicine formula Lily Bulb and Rehmannia Decoction in the treatment of depression. Biomed Pharmacother 112:108616

[27] Clemente JC, Ursell LK, Parfrey LW, Knight R (2012) The impact of the gut microbiota on human health: an integrative view. Cell 148:1258–1270

[28] Cockburn DW, Koropatkin NM (2016) Polysaccharide degradation by the intestinal microbiota and its influence on human health and disease. J Mol Biol 428:3230–3252

[29] Conlon MA, Bird AR (2014) The impact of diet and lifestyle on gut microbiota and human health. Nutrients 7:17–44

[30] Creekmore BC, Gray JH, Walton WG, Biernat KA, Little MS, Xu Y, Liu J, Gharaibeh RZ, Redinbo MR (2019) Mouse gut microbiomeencoded beta-glucuronidases identified using metagenome analysis guided by protein structure. Systems 4:e00452–19

[31] Dabek M, McCrae SI, Stevens VJ, Duncan SH, Louis P (2008) Distribution of beta-glucosidase and beta-glucuronidase activity and of beta-glucuronidase gene gus in human colonic bacteria. FEMS Microbiol Ecol 66:487–495

[32] Deng Z, Jing WG, Wang SH, Jiao MJ, Zhang Q, Zhou HY, Zhang J, Liu A (2019) Discussion and research progress in standard decoction of medicinal slices. Zhongguo Zhong Yao Za Zhi 44:242–248

[33] Devillard E, McIntosh FM, Duncan SH, Wallace RJ (2007) Metabolism of linoleic acid by human gut bacteria: different routes for biosynthesis of conjugated linoleic acid. J Bacteriol 189:2566–2570

[34] Devkota S, Wang Y, Musch MW, Leone V, Fehlner-Peach H, Nadimpalli A, Antonopoulos DA, Jabri B, Chang EB (2012) Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/mice. Nature 487:104–108

[35] Dey P (2019) Gut microbiota in phytopharmacology: a comprehensive overview of concepts, reciprocal interactions, biotransformations and mode of actions. Pharmacol Res 147:104367

[36] Di S, Wang Y, Han L, Bao Q, Gao Z, Wang Q, Yang Y, Zhao L, Tong X (2019) The intervention effect of traditional Chinese medicine on the intestinal flora and its metabolites in glycolipid metabolic disorders. Evid Based Complement Alternat Med 2019:2958920

[37] Ding Z, Zhong R, Xia T, Yang Y, Xing N, Wang W, Wang Y, Yang B, Sun X, Shu Z (2020) Advances in research into the mechanisms of Chinese Materia Medica against acute lung injury. Biomed Pharmacother 122:109706

[38] Esteban-Gil A, Perez-Sanz F, Garcia-Solano J, Alburquerque BGonzalez MA, Parreno-Gonzalez MDC, Legaz-Garcia JT, Fernandez-Breis E, Rodriguez-Braun P, Pimentel A, Tuomisto (2019) ColPortal, an integrative multiomic platform for analysing epigenetic interactions in colorectal cancer. Sci Data 6:255

[39] Feng Q, Gou X-J, Meng S-X, Huang C, Zhang Y-Q, Tang Y-J, Wang W-J, Xu L, Peng J, Hu Y-Y (2013) Qushi Huayu decoction inhibits hepatic lipid accumulation by activating AMP-activated protein kinase in vivo and in vitro. Evid-Based Complement Alterna Med: eCAM 2013:184358

[40] Feng W, Ao H, Peng C, Yan D (2019) Gut microbiota, a new frontier to understand traditional Chinese medicines. Pharmacol Res 142:176–191

[41] Gao K, Yang R, Zhang J, Wang Z, Jia C, Zhang F, Li S, Wang J, Murtaza G, Xie H (2018) Effects of Qijian mixture on type 2 diabetes assessed by metabonomics, gut microbiota and network pharmacology. Pharmacol Res 130:93–109

[42] Gao W, Guo SZ, Han LW, Zhang FZ (2016) Analysis of projects funded by NSFC in field of Chinese material medica resource in recent three years. Zhongguo Zhong Yao Za Zhi 41:3696–3701

[43] Gentile CL, Weir TL (2018) The gut microbiota at the intersection of diet and human health. Science 362:776–780

[44] Gerard P (2013) Metabolism of cholesterol and bile acids by the gut microbiota. Pathogens 3:14–24

[45] Ghazalpour A, Cespedes I, Bennett BJ, Allayee H (2016) Expanding role of gut microbiota in lipid metabolism. Curr Opin Lipidol 27:141–147

[46] Han Y, Li C, Huan Y, Sun S, Mu Y, Shen Z (2016) Effects of berberine compatible with stachyose on glucolipid metabolism and gut microbiota in diabetic mice. Chin J Clin Pharmacol 32:1121–1124

[47] Hao YF, Jiang JG (2015) Origin and evolution of China Pharmacopoeia and its implication for traditional medicines. Mini Rev Med Chem 15:595–603

[48] Hu HC, Zheng LT, Yin HY, Tao Y, Luo XQ, Wei KS, Yin LP (2019) A significant association between rhein and diabetic nephropathy in animals: a systematic review and meta-analysis. Front Pharmacol 10:1473

[49] Huang X, Chen W, Yan C, Yang R, Chen Q, Xu H, Huang Y (2019) Gypenosides improve the intestinal microbiota of non-alcoholic fatty liver in mice and alleviate its progression. Biomed Pharmacother 118:109258

[50] Humblot C, Murkovic M, Rigottier-Gois L, Bensaada M, Bouclet A, Andrieux C, Anba J, Rabot S (2007) Beta-glucuronidase in human intestinal microbiota is necessary for the colonic genotoxicity of the food-borne carcinogen 2-amino-3-methylimidazo [4,5-f]quinoline in rats. Carcinogenesis 28:2419–2425

[51] Hussain A, Yadav MK, Bose S, Wang JH, Lim D, Song YK, Ko SG, Kim H (2016) Daesiho-Tang is an effective herbal formulation in attenuation of obesity in mice through alteration of gene expression and modulation of intestinal microbiota. PLoS ONE 11: e0165483

[52] Janeiro MH, Ramirez MJ, Milagro FI, Martinez JA, Solas M (2018) Implication of trimethylamine N-Oxide (TMAO) in disease: potential biomarker or new therapeutic target. Nutrients 10 (10):1398

[53] Jia W, Xie G, Jia W (2018) Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat Rev Gastroenterol Hepatol 15:111–128

[54] Jiang Y, Liu M, Liu H, Liu S (2020) A critical review: traditional uses, phytochemistry, pharmacology and toxicology of Stephania tetrandra S. Moore (Fen Fang Ji). Phytochem Rev 19:449–489

[55] Jin R, Lin ZJ, Xue CM, Zhang B (2013) An improved associationmining research for exploring Chinese herbal property theory: based on data of the Shennong’s Classic of Materia Medica. J Integr Med 11:352–365

[56] Kaur H, Bose C, Mande SS (2019) Tryptophan metabolism by gut microbiome and gut-brain-axis: an in silico analysis. Front Neurosci 13:1365

[57] Kikugawa K, Kato T (1988) Formation of a mutagenic diazoquinone by interaction of phenol with nitrite. Food and Chemical Toxicology 26:209–214

[58] Kim DH (2018) Gut microbiota-mediated pharmacokinetics of ginseng saponins. J Ginseng Res 42:255–263

[59] Kim HM, Song Y, Hyun GH, Long NP, Park JH, Hsieh YSY, Kwon SW (2020) Characterization and Antioxidant Activity Determination of Neutral and Acidic Polysaccharides from Panax Ginseng C.A. Meyer. Molecules 25:791

[60] Kim KA, Jung IH, Park SH, Ahn YT, Huh CS, Kim DH (2013) Comparative analysis of the gut microbiota in people with different levels of ginsenoside Rb1 degradation to compound K. PLoS One 8:e62409

[61] Koropatkin NM, Cameron EA, Martens EC (2012) How glycan metabolism shapes the human gut microbiota. Nat Rev Microbiol 10:323–335

[62] Lagier JC, Dubourg G, Million M, Cadoret F, Bilen M, Fenollar F, Levasseur A, Rolain JM, Fournier PE, Raoult D (2018) Culturing the human microbiota and culturomics. Nat Rev Microbiol 16:540–550

[63] Lee JW, Na D, Park JM, Lee J, Choi S, Lee SY (2012) Systems metabolic engineering of microorganisms for natural and nonnatural chemicals. Nat Chem Biol 8:536–546

[64] Leng J, Huang F, Hai Y, Tian H, Liu W, Fang Y, Hu Y, Peng J (2020) Amelioration of non-alcoholic steatohepatitis by Qushi Huayu decoction is associated with inhibition of the intestinal mitogenactivated protein kinase pathway. Phytomedicine 66:153135

[65] Li C, Du X, Liu Y, Liu QQ, Zhi WB, Wang CL, Zhou J, Li Y, Zhang H (2020) A systems pharmacology approach for identifying the multiple mechanisms of action for the Rougui-Fuzi Herb pair in the treatment of cardiocerebral vascular diseases. Evid Based Complement Alternat Med 2020:5196302

[66] Li G, Wang D, Fang S, Xu M (2014) Textual research on Costus root (Aucklandia lappa Decne) in the Sheng nong ben cao jing (Shennong’s Classic of Materia Medica). Zhonghua Yi Shi Za Zhi 44:135–137

[67] Li LC, Kan LD (2017) Traditional Chinese medicine for pulmonary fibrosis therapy: Progress and future prospects. J Ethnopharmacol 198:45–63

[68] Li SP, Wu D-T, Lv G-P, Zhao J (2013) Carbohydrates analysis in herbal glycomics. TrAC Trends Anal Chem 52:155–169

[69] Lin CS, Chang CJ, Lu CC, Martel J, Ojcius DM, Ko YF, Young JD, Lai HC (2014) Impact of the gut microbiota, prebiotics, and probiotics on human health and disease. Biomed J 37:259–268

[70] Lin L, Ni B, Lin H, Zhang M, Li X, Yin X, Qu C, Ni J (2015) Traditional usages, botany, phytochemistry, pharmacology and toxicology of Polygonum multiflorum Thunb.: a review. J Ethnopharmacol 159:158–183

[71] Lin R, Liu W, Piao M, Zhu H (2017) A review of the relationship between the gut microbiota and amino acid metabolism. Amino Acids 49:2083–2090

[72] Lin T-L, Shu C-C, Lai W-F, Tzeng C-M, Lai H-C, Lu C-C (2019) Investiture of next generation probiotics on amelioration of diseases—strains do matter. Med Microecol 1–2:100002

[73] Liu C, Li S, Zhang Q, Guo F, Tong M, Martinez M, Wang HH, Zhao Y, Shang D (2019a) Emerging role of chinese herbal medicines in the treatment of pancreatic fibrosis. Am J Chin Med 47:709–726

[74] Liu D, Zhang Y, Liu Y, Hou L, Li S, Tian H, Zhao T (2018a) Berberine modulates gut microbiota and reduces insulin resistance via the TLR4 signaling pathway. Exp Clin Endocrinol Diabetes 126:513–520

[75] Liu M, Wang Y, Liu Y, Ruan R (2016) Bioactive peptides derived from traditional Chinese medicine and traditional Chinese food: a review. Food Res Int 89:63–73

[76] Liu S, Si C, Yu Y, Zhao G, Chen L, Zhao Y, Zhang Z, Li H, Chen Y, Min L (2019b) Multi-omics analysis of gut microbiota and metabolites in rats with irritable bowel syndrome. Front Cell Infect Microbiol 9:178

[77] Liu Y, Li J, Yu J, Wang Y, Lu J, Shang EX, Zhu Z, Guo J, Duan J (2018b) Disorder of gut amino acids metabolism during CKD progression is related with gut microbiota dysbiosis and metagenome change. J Pharm Biomed Anal 149:425–435

[78] Lloyd-Price J, Arze C, Ananthakrishnan AN, Schirmer M, AvilaPacheco J, Poon TW, Andrews E, Ajami NJ, Bonham KS, Brislawn CJ (2019) Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature 569:655–662

[79] Lu Y-M, Xie J-J, Peng C-G, Wang B-H, Wang K-C, Li L-J (2019) Enhancing clinical efficacy through the gut microbiota: a new field of traditional Chinese medicine. Engineering 5:40–49

[80] Lyu M, Wang YF, Fan GW, Wang XY, Xu SY, Zhu Y (2017) Balancing herbal medicine and functional food for prevention and treatment of cardiometabolic diseases through modulating gut microbiota. Front Microbiol 8:2146

[81] Ma N, Tian Y, Wu Y, Ma X (2017) Contributions of the interaction between dietary protein and gut microbiota to intestinal health. Curr Protein Pept Sci 18:795–808

[82] Madsen L, Myrmel LS, Fjaere E, Liaset B, Kristiansen K (2017) Links between dietary protein sources, the gut microbiota, and obesity. Front Physiol 8:1047

[83] Magee EA, Richardson CJ, Hughes R, Cummings JH (2000) Contribution of dietary protein to sulfide production in the large intestine: an in vitro and a controlled feeding study in humans. Am J Clin Nutr 72:1488–1494

[84] Marques TM, Wall R, O’Sullivan O, Fitzgerald GF, Shanahan F, Quigley EM, Cotter PD, Cryan JF, Dinan TG, Ross RP (2015) Dietary trans-10, cis-12-conjugated linoleic acid alters fatty acid metabolism and microbiota composition in mice. Br J Nutr 113:728–738

[85] Martel J, Ko YF, Ojcius DM, Lu CC, Chang CJ, Lin CS, Lai HC, Young JD (2017a) Immunomodulatory properties of plants and mushrooms. Trends Pharmacol Sci 38:967–981

[86] Martel J, Ojcius DM, Chang CJ, Lin CS, Lu CC, Ko YF, Tseng SF, Lai HC, Young JD (2017b) Anti-obesogenic and antidiabetic effects of plants and mushrooms. Nat Rev Endocrinol 13:149–160

[87] Martens EC, Lowe EC, Chiang H, Pudlo NA, Wu M, McNulty NP, Abbott DW, Henrissat B, Gilbert HJ, Bolam DN (2011) Recognition and degradation of plant cell wall polysaccharides by two human gut symbionts. PLoS Biol 9:e1001221

[88] Mazzoli R, Pessione E (2016) The neuro-endocrinological role of microbial glutamate and GABA signaling. Front Microbiol 7:1934

[89] Mishima E, Fukuda S, Mukawa C, Yuri A, Kanemitsu Y, Matsumoto Y, Akiyama Y, Fukuda NN, Tsukamoto H, Asaji K (2017) Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach. Kidney Int 92:634–645

[90] Neis EP, Dejong CH, Rensen SS (2015) The role of microbial amino acid metabolism in host metabolism. Nutrients 7:2930–2946

[91] Ni M (1995) The yellow emperor’s classic of medicine: a new translation of the Neijing Suwen with commentary. Shambhala, Boston and London

[92] Nie C, He T, Zhang W, Zhang G, Ma X (2018) Branched chain amino acids: beyond nutrition metabolism. Int J Mol Sci. 1:1. https://doi.org/10.1136/gutjnl-2019-319114

[93] Nie Q, Chen H, Hu J, Fan S, Nie S (2019) Dietary compounds and traditional Chinese medicine ameliorate type 2 diabetes by modulating gut microbiota. Crit Rev Food Sci Nutr 59:848–863

[94] Peng Y, Li X, Zhang S, Liu Z, Ji J, Wu C, Yang J (2020) Gut microbiota and Chinese medicine syndrome: altered fecal microbiotas in spleen (Pi)-deficient patients. J Tradit Chin Med 40:137–143

[95] Portune KJ, Beaumont M, Davila A-M, Tomé D, Blachier F, Sanz Y (2016) Gut microbiota role in dietary protein metabolism and health-related outcomes: the two sides of the coin. Trends Food Sci Technol 57:213–232

[96] Qi LW, Wang CZ, Du GJ, Zhang ZY, Calway T, Yuan CS (2011) Metabolism of ginseng and its interactions with drugs. Curr Drug Metab 12:818–822

[97] Qu W, Liu S, Zhang W, Zhu H, Tao Q, Wang H, Yan H (2019) Impact of traditional Chinese medicine treatment on chronic unpredictable mild stress-induced depression-like behaviors: intestinal microbiota and gut microbiome function. Food Funct 10:5886–5897

[98] Quan LH, Zhang C, Dong M, Jiang J, Xu H, Yan C, Liu X, Zhou H, Zhang H, Chen L (2019) Myristoleic acid produced by enterococci reduces obesity through brown adipose tissue activation. Gut. 69(7):1239–1247

[99] Ramesh M, Ahlawat P, Srinivas NR (2010) Irinotecan and its active metabolite, SN-38: review of bioanalytical methods and recent update from clinical pharmacology perspectives. Biomed Chro matogr 24:104–123

[100] Ramirez-Perez O, Cruz-Ramon V, Chinchilla-Lopez P, Mendez NSanchez (2017) The role of the gut microbiota in bile acid metabolism. Ann Hepatol 16:s15–s20

[101] Rath S, Heidrich B, Pieper DH, Vital M (2017) Uncovering the trimethylamine-producing bacteria of the human gut microbiota. Microbiome 5:54

[102] Ravcheev DA, Godzik A, Osterman AL, Rodionov DA (2013) Polysaccharides utilization in human gut bacterium Bacteroides thetaiotaomicron: comparative genomics reconstruction of metabolic and regulatory networks. BMC Genomics 14:873

[103] Ru J, Li P, Wang J, Zhou W, Li B, Huang C, Li P, Guo Z, Tao W, Yang Y (2014) TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform 6:13

[104] Santa HSD, Romão PRT, Sovrani V, Oliveira FR, Peres A, Monteiro MC (2014) Dietary polysaccharidesand Immune Modulation. In: Ramawat KG, Mérillon J-M (eds) Polysaccharides: bioactivity and biotechnology. Springer International Publishing, Cham, pp 1–24

[105] Schachter J, Martel J, Lin CS, Chang CJ, Wu TR, Lu CC, Ko YF, Lai HC, Ojcius DM, Young JD (2018) Effects of obesity on depression: a role for inflammation and the gut microbiota. Brain Behav Immun 69:1–8

[106] Schoeler M, Caesar R (2019) Dietary lipids, gut microbiota and lipid metabolism. Rev Endocr Metab Disord 20:461–472

[107] Schwiertz A, Taras D, Schafer K, Beijer S, Bos NA, Donus C, Hardt PD (2010) Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 18:190–195

[108] Sharon G, Garg N, Debelius J, Knight R, Dorrestein PC, Mazmanian SK (2014) Specialized metabolites from the microbiome in health and disease. Cell Metab 20:719–730

[109] Simpson HL, Campbell BJ (2015) Review article: dietary fibremicrobiota interactions. Aliment Pharmacol Ther 42:158–179

[110] Sun SS, Wang K, Ma K, Bao L, Liu HW (2019) An insoluble polysaccharide from the sclerotium of Poria cocos improves hyperglycemia, hyperlipidemia and hepatic steatosis in ob/ob mice via modulation of gut microbiota. Chin J Nat Med 17:3–14

[111] Sun Y (2011) Structure and biological activities of the polysaccharides from the leaves, roots and fruits of Panax ginseng C.A. Meyer: an overview. Carbohydrate Polymers CARBOHYD POLYM 85:490–499

[112] Tang D, Kang R, Coyne CB, Zeh HJ, Lotze MT (2012) PAMPs and DAMPs: signal 0s that spur autophagy and immunity. Immunol Rev 249:158–175

[113] Teijaro CN, Adhikari A, Shen B (2019) Challenges and opportunities for natural product discovery, production, and engineering in native producers versus heterologous hosts. J Ind Microbiol Biotechnol 46:433–444

[114] Thursby E, Juge N (2017) Introduction to the human gut microbiota. Biochem J 474:1823–1836

[115] Tong X, Xu J, Lian F, Yu X, Zhao Y, Xu L, Zhang M, Zhao X, Shen J, Wu S (2018) Structural alteration of gut microbiota during the amelioration of human type 2 diabetes with hyperlipidemia by metformin and a traditional Chinese herbal formula: a multicenter, randomized, Open label clinical trial. mBio. 9(3):e02392–17

[116] Tremaroli V, Backhed F (2012) Functional interactions between the gut microbiota and host metabolism. Nature 489:242–249

[117] Tsai YL, Lin TL, Chang CJ, Wu TR, Lai WF, Lu CC, Lai HC (2019) Probiotics, prebiotics and amelioration of diseases. J Biomed Sci 26:3

[118] Tzianabos AO (2000) Polysaccharide immunomodulators as therapeutic agents: structural aspects and biologic function. Clin Microbiol Rev 13:523–533

[119] van Duynhoven J, Vaughan EE, Jacobs DM, Kemperman RA, van Velzen EJ, Gross G, Roger LC, Possemiers S, Smilde AK, Dore J (2011) Metabolic fate of polyphenols in the human superorganism. Proc Natl Acad Sci USA 108(Suppl 1):4531–4538

[120] Velenosi TJ, Hennop A, Feere DA, Tieu A, Kucey AS, Kyriacou P, McCuaig LE, Nevison SE, Kerr MA, Urquhart BL (2016) Untargeted plasma and tissue metabolomics in rats with chronic kidney disease given AST-120. Sci Rep 6:22526

[121] Wahlstrom A, Sayin SI, Marschall HU, Backhed F (2016) Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab 24:41–50

[122] Wan JY, Wang CZ, Zhang QH, Liu Z, Musch MW, Bissonnette M, Chang EB, Li P, Qi LW, Yuan CS (2017) Significant difference in active metabolite levels of ginseng in humans consuming Asian or Western diet: the link with enteric microbiota. Biomed Chro matogr. https://doi.org/10.1002/bmc.3851

[123] Wang B, Yao M, Lv L, Ling Z, Li L (2017a) The human microbiota in health and disease. Engineering 3:71–82

[124] Wang C, Yin Y, Cao X, Li X (2016) Effects of Maydis stigma polysaccharide on the intestinal microflora in type-2 diabetes. Pharm Biol 54:3086–3092

[125] Wang JH, Bose S, Lim SK, Ansari A, Chin YW, Choi HS, Kim H (2017b) Houttuynia cordata facilitates metformin on ameliorating insulin resistance associated with gut microbiota alteration in OLETF rats. Genes (Basel) 8:239

[126] Wang JH, Bose S, Shin NR, Chin YW, Choi YH, Kim H (2018a) Pharmaceutical impact of houttuynia cordata and metformin combination on high-fat-diet-induced metabolic disorders: link to intestinal microbiota and metabolic endotoxemia. Front Endocrinol (Lausanne) 9:620

[127] Wang L, Liu QM, Sung BH, An DS, Lee HG, Kim SG, Kim SC, Lee ST, Im WT (2011) Bioconversion of ginsenosides Rb(1), Rb(2), Rc and Rd by novel beta-glucosidase hydrolyzing outer 3-O glycoside from Sphingomonas sp. 2F2: cloning, expression, and enzyme characterization. J Biotechnol 156:125–133

[128] Wang Q, Kuang H, Su Y, Sun Y, Feng J, Guo R, Chan K (2013) Naturally derived anti-inflammatory compounds from Chinese medicinal plants. J Ethnopharmacol 146:9–39

[129] Wang R, Zang P, Chen J, Wu F, Zheng Z, Ma J, Yang C, Du H (2018b) Gut microbiota play an essential role in the antidiabetic effects of rhein. Evid Based Complement Alternat Med 2018:6093282

[130] Wei X, Tao J, Xiao S, Jiang S, Shang E, Zhu Z, Qian D, Duan J (2018) Xiexin Tang improves the symptom of type 2 diabetic rats by modulation of the gut microbiota. Sci Rep 8:3685

[131] Wu TR, Lin CS, Chang CJ, Lin TL, Martel J, Ko YF, Ojcius DM, Lu CC, Young JD, Lai HC (2019) Gut commensal Parabacteroides goldsteinii plays a predominant role in the anti-obesity effects of polysaccharides isolated from Hirsutella sinensis. Gut 68:248–262

[132] Wu XM, Tan RX (2019) Interaction between gut microbiota and ethnomedicine constituents. Nat Prod Rep 36:788–809

[133] Xu J, Lian F, Zhao L, Zhao Y, Chen X, Zhang X, Guo Y, Zhang C, Zhou Q, Xue Z (2015) Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula. ISME J 9:552–562

[134] Xu JD, Mao Q, Shen H, Zhu LY, Li SL, Yan R (2013) Ultra-high performance liquid chromatography coupled with photo-diode array and quadrupole/time-of-flight mass spectrometry based chemical profiling approach to evaluate the influence of preparation methods on the holistic quality of Qiong-Yu-Gao, a traditional complex herbal medicine. J Chromatogr A 1304:154–168

[135] Xu M, Yue RS, Yang MY, Yang X, Wu TC, Li JN (2018) Effects of Banxia Xiexin Decoction on intestinal flora and inflammatory factors of diabetic gastroparesis rats. Chinese Traditional and Herbal Drugs 49:3056–3061

[136] Yan Q (2018) Neuroimmune imbalances and Yin-Yang dynamics in stress, anxiety, and depression. Methods Mol Biol 1781:77–85

[137] Yan Y, Chai CZ, Wang DW, Yue XY, Zhu DN, Yu BY (2013) HPLC-DAD-Q-TOF-MS/MS analysis and HPLC quantitation of chemical constituents in traditional Chinese medicinal formula Ge-Gen Decoction. J Pharm Biomed Anal 80:192–202

[138] Yang M, Lao L (2019) Emerging applications of metabolomics in traditional Chinese medicine treating hypertension: biomarkers. Pathways and More. Front Pharmacol 10:158

[139] Yang M, Sun J, Lu Z, Chen G, Guan S, Liu X, Jiang B, Ye M, Guo DA (2009) Phytochemical analysis of traditional Chinese medicine using liquid chromatography coupled with mass spectrometry. J Chromatogr A 1216:2045–2062

[140] Yang YS, Zhang T, Yu SC, Ding Y, Zhang LY, Qiu C, Jin D (2011) Transformation of geniposide into genipin by immobilized betaglucosidase in a two-phase aqueous-organic system. Molecules 16:4295–4304

[141] Ying M, Zheng B, Yu Q, Hou K, Wang H, Zhao M, Chen Y, Xie J, Nie S, Xie M (2020) Ganoderma atrum polysaccharide ameliorates intestinal mucosal dysfunction associated with autophagy in immunosuppressed mice. Food Chem Toxicol 138:111244

[142] Yokoi T, Narita M, Nagai E, Hagiwara H, Aburada M, Kamataki T (1995) Inhibition of UDP-glucuronosyltransferase by aglycons of natural glucuronides in kampo medicines using SN-38 as a substrate. Jpn J Cancer Res 86:985–989

[143] Yu J, Guo J, Tao W, Liu P, Shang E, Zhu Z, Fan X, Shen J, Hua Y, Zhu KY (2018a) Gancao-Gansui combination impacts gut microbiota diversity and related metabolic functions. J Ethnopharmacol 214:71–82

[144] Yu Y, Li Z, Guo R, Qian J, Zhang H, Zhang J, Zhao X, Wang S, Wang Y (2019a) Ononin, sec-O-beta-d-glucosylhamaudol and astragaloside I: antiviral lead compounds identified via high throughput screening and biological validation from traditional Chinese medicine Zhongjing formulary. Pharmacol Res 145:104248

[145] Yu Y, Raka F, Adeli K (2019b) The role of the gut microbiota in lipid and lipoprotein metabolism. J Clin Med 8(12):2227

[146] Yu Y, Shen M, Song Q, Xie J (2018b) Biological activities and pharmaceutical applications of polysaccharide from natural resources: a review. Carbohydr Polym 183:91–101

[147] Yuan Y, Zheng J, Wang M, Li Y, Ruan J, Zhang H (2016) Metabolic activation of rhein: insights into the potential toxicity induced by rhein-containing herbs. J Agric Food Chem 64:5742–5750

[148] Yue SJ, Wang WX, Yu JG, Chen YY, Shi XQ, Yan D, Zhou GS, Zhang L, Wang CY, Duan JA (2019) Gut microbiota modulation with traditional Chinese medicine: a system biologydriven approach. Pharmacol Res 148:104453

[149] Zhang B, Yue R, Chen Y, Yang M, Huang X, Shui J, Peng Y, Chin J (2019a) Gut microbiota, a potential new target for Chinese herbal medicines in treating diabetes mellitus. Evid Based Complement Alternat Med 2019:2634898

[150] Zhang D, Chia C, Jiao X, Jin W, Kasagi S, Wu R, Konkel JE, Nakatsukasa H, Zanvit P, Goldberg N (2017) D-mannose induces regulatory T cells and suppresses immunopathology. Nat Med 23:1036–1045

[151] Zhang D, Yang L, Yang LX, Wang MY, Tu YY (2007) Determination of artemisinin, arteannuin B and artemisinic acid in Herba Artemisiae Annuae by HPLC-UV-ELSD. Yao Xue Xue Bao 42:978–981

[152] Zhang D, Zhang Y, Gao Y, Chai X, Pi R, Chan G, Hu Y (2020a) Translating traditional herbal formulas into modern drugs: a network-based analysis of Xiaoyao decoction. Chin Med 15:25

[153] Zhang ND, Han T, Huang BK, Rahman K, Jiang YP, Xu HT, Qin LP, Xin HL, Zhang QY, Li YM (2016) Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery. J Ethnopharmacol 189:61–80

[154] Zhang R, Gao X, Bai H, Ning K (2020b) Traditional Chinese medicine and gut microbiome: their respective and concert effects on healthcare. Front Pharmacol 1:1. https://doi.org/10.3389/fphar.2020.00538

[155] Zhang T, Yang Y, Liang Y, Jiao X, Zhao C (2018) Beneficial effect of intestinal fermentation of natural polysaccharides. Nutrients 10 (8):55

[156] Zhang WJ, Wang S, Kang CZ, Lv CG, Zhou L, Huang LQ, Guo LP (2020c) Pharmacodynamic material basis of traditional Chinese medicine based on biomacromolecules: a review. Plant Methods 16:26

[157] Zhang YL, Cai LT, Qi JY, Lin YZ, Dai YC, Jiao N, Chen YL, Zheng L, Wang BB, Zhu LX (2019b) Gut microbiota contributes to the distinction between two traditional Chinese medicine syndromes of ulcerative colitis. World J Gastroenterol 25:3242–3255

[158] Zhao CQ, Zhou Y, Ping J, Xu LM (2014) Traditional Chinese medicine for treatment of liver diseases: progress, challenges and opportunities. J Integr Med 12:401–408

[159] Zhou SS, Xu J, Zhu H, Wu J, Xu JD, Yan R, Li XY, Liu HH, Duan SM, Wang Z (2016) Gut microbiota-involved mechanisms in enhancing systemic exposure of ginsenosides by coexisting polysaccharides in ginseng decoction. Sci Rep 6:22474

[160] Zhu KX, Nie SP, Tan LH, Li C, Gong DM, Xie MY (2016) A polysaccharide from ganoderma atrum improves liver function in type 2 diabetic rats via antioxidant action and short-chain fatty acids excretion. J Agric Food Chem 64:1938–1944

[161] Zmora N, Suez J, Elinav E (2019) You are what you eat: diet, health and the gut microbiota. Nat Rev Gastroenterol Hepatol 16:35

RIGHTS & PERMISSIONS

2020 The Author(s)